Medical/Pharmaceuticals
Shanghai Cellular Biopharmaceutical Group presents first data from Phase I trial evaluating a novel CAR-T in advanced liver cancer at AACR Annual Meeting
Promising anti-tumor activity reported for C-CAR031, a novel Glypican 3 (GPC3)-targeting cell therapy designed by AstraZeneca SHANGHAI, April 18, 2023 /PRNewswire/ -- Shanghai Cellular Biopharmaceutical Group Ltd. (the Company, or Shanghai Cellular Bio), a company engaged in the drug development...
2023-04-18 04:15
1926
Antengene Announces Five Presentations at the 2023 American Association for Cancer Research Meeting
* Five posters showcased progress with multiple preclinical and clinical programs, includingATG-008 (mTORC1/2 inhibitor), ATG-017 (ERK1/2 inhibitor), ATG-037 (CD73 inhibitor), ATG-031 (anti-CD24 monoclonal antibody) and ATG-034 (LILRB4 antagonist antibody) * Clinical results showed promising ...
2023-04-17 20:22
2273
Telix Reports Q1 2023 Financial Results: Delivers First $100M Revenue Quarter
MELBOURNE, Australia, April 17, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today issues its Appendix 4C quarterly cash flow statement and accompanying Activities Report for the quarter ended31 March 2023 (Q1 2023). All figures are in AUD$ unless otherwise st...
2023-04-17 18:15
2303
World Hemophilia Day 2023 - "Access for All: Prevention of bleeds as the global standard of care"
MONTREAL, April 17, 2023 /PRNewswire/ -- April 17, 2023 is World Hemophilia Day. The theme of the event this year is "Access for All: Prevention of bleeds as the global standard of care". Building on last year's theme, the call to action for the community in 2023 is to come together and advocate ...
2023-04-17 17:00
1465
Late-Breaking Research - Alphamab Oncology Presents Preclinical Results of KN052 at AACR 2023
SUZHOU, China, April 17, 2023 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the preclinical result of KN052 (PD-L1/OX40 bispecific antibody) were presented as a poster at the Late-Breaking Research session of the AACR Annual Meeting 2023 (AACR 2023). The AACR Annual Meet...
2023-04-17 14:01
2131
EBMI INKED MOA WITH SFIO TO BUILD A WORLD-CLASSS INTEGRATIVE CARE FACILITY IN PALAWAN, PHILIPPINES
MANILA, Philippines, April 17, 2023 /PRNewswire/ -- European Biological Medicine Inc., a subsidiary of European Wellness Biomedical Group (EW Group) has inked a Memorandum of Agreement (MoA) with Starfleet Innotech, Inc. (SFIO) to build a world-class integrative care facility in Palawan,Philippin...
2023-04-17 11:00
2893
AffaMed Therapeutics Announces Approval to Initiate a Phase 3 Registrational Clinical Trial in Mainland China for DEXTENZA® for the Treatment of Ocular Inflammation and Pain Following Ophthalmic Surgery
SHANGHAI, April 17, 2023 /PRNewswire/ -- AffaMed Therapeutics ("AffaMed"), a global biotechnology company dedicated to developing and commercializing transformative pharmaceutical, digital and surgical products that address critical unmet medical needs in ophthalmological, neurological and psychi...
2023-04-17 09:00
4522
Innovent Releases Final Analysis Results of ORIENT-15: the Phase 3 Study of Sintilimab plus Chemotherapy for the First-Line Treatment of Esophageal Squamous Cell Carcinoma at the AACR Annual Meeting 2023
ROCKVILLE, Md. and SUZHOU, China, April 17, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology a...
2023-04-17 08:33
3383
Abbisko presents the research results of 5 programs at the 2023 AACR Annual Meeting
SHANGHAI, April 17, 2023 /PRNewswire/ -- Abbisko (Stock Code: 2256.HK)
announced the results of five latest preclinical studies at the 2023 American
Association for Cancer Research (AACR) annual meeting.
2023-04-17 08:30
3316
Henlius Achieved Steep Revenue Growth in Q1 2023, Core Products Sales Surged
SHANGHAI, April 17, 2023 /PRNewswire/ -- As a global innovative biopharmaceutical company, Henlius is committed to offering high-quality, affordable and innovative biopharmaceuticals to patients worldwide with 5 products launched inChina. Leveraging the differentiated competitive edges of its pr...
2023-04-17 07:45
2369
Bugworks Research Inc. to Present Eight Posters at the 33rd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) 2023, in Copenhagen, Denmark
BANGALORE, India and DELAWARE CITY, Del. and ADELAIDE, Australia, April 17, 2023 /PRNewswire/ -- Bugworks Research Inc., a clinical-stage biopharmaceutical company, is set to present its latest research findings on the novel bacterial topoisomerase inhibitor, BWC0977 at the upcoming 33rd European...
2023-04-17 07:00
2478
Olaratumab Antibody Licensed from Lilly Demonstrates Proof of Concept as a Theranostic Radiopharmaceutical
MELBOURNE, Australia, April 17, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces successful preclinical development of radiolabelled olaratumab, an antibody licensed from Eli Lilly and Company (Lilly). Telix has demonstrated proof-of-concept (PoC) ...
2023-04-17 06:38
1947
BIOMERICS EXPANDS MANUFACTURING OPERATIONS IN TEXAS
SALT LAKE CITY, April 14, 2023 /PRNewswire/ -- Biomerics, the leading vertically integrated medical device contract manufacturer in the interventional device market, announced the completion of a 24,000 sq. ft. expansion of manufacturing operations at theirAthens, TX, facility. Driven by growth ...
2023-04-14 21:00
2345
The Goyang International Precision Medicine Center (IPMC) takes the first step at the 2023 IPMC Conference.
SEOUL, South Korea, April 14, 2023 /PRNewswire/ -- The 2023 IPMC Conference held at KINTEX in Goyang onApril 12 under the title of "Beyond Longevity: Live 120 like 50," was successfully completed after discussing futures of the longevity industry and ways to build the Goyang Int'l Precision Medic...
2023-04-14 17:00
1973
CytoMed Therapeutics Limited Announces Pricing of Initial Public Offering
SINGAPORE, April 14, 2023 /PRNewswire/ -- CytoMed Therapeutics Limited ("CytoMed" or the "Company"), a pre-clinical biopharmaceutical company focused on harnessing its licensed proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers, today announced ...
2023-04-14 08:00
4326
Agfa Healthcare Applauded by Frost & Sullivan for Improving Workflow Effectiveness, Healthcare System Quality, and Customer Value
Agfa HealthCare offers customers cloud-based medical imaging informatics, enabling remarkable scalability, reduced complexity, and a robust rule-based engine. SAN ANTONIO, April 13, 2023 /PRNewswire/ -- Recently, Frost & Sullivan analyzed the enterprise imaging industry and its evolving cloud-ba...
2023-04-13 22:00
2184
Menarini Silicon Biosystems new CELLSEARCH® data presented at AACR 2023 annual meeting highlights trailblazing contributions of liquid biopsies for cancer research
Menarini Silicon Biosystems continues to support advances in cancer research by developing new tools and solutions to automate the identification of CELLSEARCH® CTCs (Circulating Tumor Cells) through AI (Artificial Intelligence) and expand the use of liquid biopsies through the analysis of mu...
2023-04-13 20:36
1988
The Dates of the XXVII Edition of the International Fair Play Menarini Awards
FLORENCE, Italy, April 13, 2023 /PRNewswire/ -- Preparations are already underway for theInternational Fair Play Menarini Awards. This year, the event that pays tribute to athletes who demonstrate values such as ethics, loyalty and respect both in sport and in life, is in itsXXVII edition and wi...
2023-04-13 18:50
2497
Caring Pharmacy partners with Appier to deliver a personalized multi-channel experience for Malaysians
TAIPEI, April 13, 2023 /PRNewswire/ -- Appier
2023-04-13 14:00
2667
EW GROUP SHINES AT 12TH A4M SYMPOSIUM 2023 & "ALL-ON BIOREGEN OPTIMIZATION" WORKSHOP
BANGKOK, April 13, 2023 /PRNewswire/ -- European Wellness Biomedical Group (EW Group) made a successful showing at an exclusive event, the 12th A4M Symposium 2023, which was held in Centara,Bangkok, 16th-19th February 2023. The two-day A4M Symposium, commenced with a welcome ceremony featuring ...
2023-04-13 12:20
2763
Week's Top Stories
Most Reposted
QDX Co-Founder Giuseppe Barca Awarded Prestigious Gordon Bell Prize, Pioneering Advancements in Drug Discovery Technology
[Picked up by 303 media titles]
2024-11-26 18:49ITAP 2024 sets the stage for a more connected advanced factory ecosystem with focus on AI, advanced robotics and sustainability
[Picked up by 296 media titles]
2024-11-28 17:24Southeast Asian Consumers Raise Online Security Concerns, New GSMA Survey Shows
[Picked up by 296 media titles]
2024-11-26 13:00MediSun Energy Raises $8.75M Seed Round with Vynn Capital to Drive MENA Expansion and Advance Osmotic Energy Innovation
[Picked up by 280 media titles]
2024-11-25 10:00
Announcement of "Cyber Sousa Award" Winners of the 16th Xiamen International Animation Festival
[Picked up by 272 media titles]
2024-11-26 16:48
Most Read
Chinese path to modernization a model for Global South, experts say
2024-11-23 15:35
12916
SUNLU Formnext 2024 Event Highlights: From Functional Filaments to FilaDryer E2
2024-11-23 21:00
9000
Innovative technology and applications recognised with Hong Kong ICT Awards 2024
2024-11-23 02:02
8155
